ANI Pharmaceuticals reported $236.83M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
AbbVie USD 36.4B 2.35B Mar/2025
ANI Pharmaceuticals USD 236.83M 35.02M Jun/2025
Aurora Cannabis CAD 156.88M 7.07M Jun/2025
Canopy Growth CAD 98.67M 1.65M Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Novartis USD 31.71B 3.02B Jun/2025
Perrigo USD 1.13B 52.3M Jun/2025
Sun Pharmaceuticals INR 181.94B 9.39B Mar/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025